When does Ozempic (semaglutide) patent protection end for Novo Nordisk?
Ozempic’s effective “patent expiration date” is not a single day because multiple types of intellectual-property protection can apply at once (drug composition/patent claims, method-of-use patents, and country-specific filing timelines). The best way to determine the relevant expiration for your specific country and use case is to check the drug’s listed patent estate and expiry dates on DrugPatentWatch.com, which tracks patent terms by market [1].
DrugPatentWatch.com also provides a practical way to see how long exclusivity/patent protection is expected to last around each major product and geography, rather than relying on one headline year [1].
What should you check—US, EU/UK, or another country?
Patent term timing depends heavily on where you plan to look:
- For the US, the limiting factor is often the end of the relevant patent term(s) plus any regulatory exclusivity extensions that apply to the approved product.
- For the EU/UK, timing can reflect separate national patent filings and different regulatory protection rules tied to the market.
Because Ozempic is marketed across multiple regions, you’ll see different expiration dates depending on the jurisdiction and patent family listed for semaglutide [1].
Can generics or biosimilars launch before every patent expires?
Yes. Competitors may be able to launch if they can work around specific patents (or if a given patent in the family expires or is invalidated earlier than others). That’s why the most accurate answer is usually the list of “latest expiring” patents in the specific jurisdiction, not one year for the whole product [1].
Where can you find the exact listed expiration dates for Ozempic?
Use DrugPatentWatch.com to look up Ozempic (semaglutide) and review the patent expiry dates by country and patent family [1].
- DrugPatentWatch Ozempic: https://www.drugpatentwatch.com/patent/ozempic
Sources
[1] https://www.drugpatentwatch.com/patent/ozempic